First-In-Class Drugs Made Up More Than Half Of US FDA’s Novel Approvals Last Year

 
• By Bridget Silverman

CDER hit a high mark with 27 first-in-class approvals in the 50 novel agents cleared in 2021.

FDA first in class
MOST NOVEL PRODUCTS THAT GRADUATED FROM FDA’s DRUG CENTER in 2021 WERE FIRST IN THEIR CLASS. • Source: Nielsen Hobbs; the Pink Sheet | Alamy image

More from Approvals

More from Product Reviews